
by Fatemeh Rahmatabadi: This week’s journal club focuses on a study from Scientific Reports (2019) exploring the the concomitant inhibition of MEK-ERK1/2 and FLT3 as a strategy to overcome drug-resistance in acute myeloid leukemia (AML).
11/3/2026 Ulrik
11/10/2026 Olena
11/17/2026 Marc
12/1/2026 Fatemeh